University of Texas Health Science Center at San Antonio: Bladder Cancer Patients Respond Well to New Immunotherapy Tested at Mays Cancer Center
March 20, 2021
March 20, 2021
SAN ANTONIO, Texas, March 20 (TNSJou) -- The University of Texas Health Science Center at San Antonio issued the following news release:
In patients with high-grade cancer in the lining of the bladder, cancer often comes back within a year following standard treatment.
Although there are several approved treatments, none have significantly improved survival with few side effects. However, a new study evaluating a novel immunotherapy called nadofaragene firadenovec (NF) . . .
In patients with high-grade cancer in the lining of the bladder, cancer often comes back within a year following standard treatment.
Although there are several approved treatments, none have significantly improved survival with few side effects. However, a new study evaluating a novel immunotherapy called nadofaragene firadenovec (NF) . . .